WebDisclosure WebDisclosure
Basculer en Français
9754 Companies
194895 Keywords
125921 Articles
103628 Press releases
Headlines Articles Press releases Simcere Pharmaceutical Group Limited Remove
  1. Home
  2. Companies
  3. Simcere Pharmaceutical Group Limited
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/27/2026 at 12:00, 4 hours 9 minutes ago

    Boehringer Ingelheim and Simcere Collaborate on IBD Treatment

    Immunology Boehringer Ingelheim Inflammatory Bowel Disease Bispecific Antibody Simcere Partnership
  • BRIEF

    published on 01/27/2026 at 12:00, 4 hours 9 minutes ago

    Boehringer Ingelheim et Simcere collaborent sur le traitement des MII

    Boehringer Ingelheim Immunologie Maladie Inflammatoire De L'intestin Anticorps Bispécifique Partenariat Simcere
  • PRESS RELEASE

    published on 01/27/2026 at 11:55, 4 hours 14 minutes ago

    Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

    Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment for inflammatory bowel disease. SIM0709, a novel bispecific antibody, aims to improve outcomes for patients worldwide
    Boehringer Ingelheim Inflammatory Bowel Disease IBD Simcere Antibody Treatment
    Logo of Simcere Pharmaceutical Group Limited
Accesswire
  • Published on 01/27/2026 at 15:00, 1 hour 9 minutes ago

    MicroVision Announces Agreement to Acquire Luminar Assets to Accelerate Commercial Strategy and Expand Product Portfolio

  • Published on 01/27/2026 at 14:45, 1 hour 24 minutes ago

    Organto Announces Appointment of Chad Hagen to the Board of Directors

  • Published on 01/27/2026 at 14:30, 1 hour 39 minutes ago

    NV Gold Announces Non-Brokered Private Placement

  • Published on 01/27/2026 at 14:23, 1 hour 46 minutes ago

    Worksport Subsidiary Terravis Energy Selects Major Asian Manufacturing Partner for Breakthrough Zerofrost(TM) Heat Pump; Announces Path to Commercialization Within 2026

  • Published on 01/27/2026 at 14:15, 1 hour 54 minutes ago

    Terravis Energy Secures Mass Manufacturing for No-Defrost Heat Pump Amid North American Polar Vortex Crisis

View all ACCESSWIRE
EQS Group
  • Published on 01/27/2026 at 15:59, 10 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Empiric Student Property plc

  • Published on 01/27/2026 at 15:58, 11 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited

  • Published on 01/27/2026 at 15:57, 12 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Rio Tinto plc and Rio Tinto Limited

  • Published on 01/27/2026 at 15:56, 13 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The

  • Published on 01/27/2026 at 15:50, 19 minutes ago

    ENOGIA: Bilan semestriel du contrat de liquidité d’ENOGIA au 31 décembre 2025

View all EQS
Les Echos
  • Published on 01/27/2026 at 14:44, 1 hour 24 minutes ago

    Chiffre d'Affaires du 3ème Trimestre 2025/2026

  • Published on 01/27/2026 at 14:05, 2 hours 4 minutes ago

    Notice of exercise of early redemption option of the subordinated note ISIN : FR0010167296

  • Published on 01/27/2026 at 14:05, 2 hours 4 minutes ago

    Exercice de l’option de remboursement de l'instrument subordonné FR0010167296

  • Published on 01/27/2026 at 14:01, 2 hours 7 minutes ago

    Notice of exercise of early redemption option of the subordinated note ISIN : FR0010167247

  • Published on 01/27/2026 at 14:01, 2 hours 7 minutes ago

    Exercice de l’option de remboursement de l'instrument subordonné FR0010167247

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy